AscellaHealth

It was a pleasure to host Charles Gayer from BioCryst Pharmaceuticals, Inc. on the AscellaHealth Podcast Pulse and have the opportunity to tap into his extensive expertise within the biopharmaceutical industry. In Part 2 of our Exclusive Distribution episode, he sat alongside AscellaHealth’s Donovan Quill to dive deep into the unique benefits of collaborating with a sole-source, exclusive distribution partner like AscellaHealth. Tune in below to hear their insightful discussion! Listen here: https://lnkd.in/eUjmthKG #AscellaHealth #Podcast #ExclusiveDistribution #HealthcareStrategy #RareDisease #SpecialtyPharmacy #LifeSciences #Innovation #Spotify  

Exciting news! We’re thrilled to introduce our latest white paper: "Transforming Global Healthcare: Establishing a Collaborative Framework for Specialty Pharmaceutical Stakeholders in the Treatment of Complex, Chronic Diseases." This evidence-based resource delves into the critical challenges life sciences companies, payers, healthcare providers, and patients currently face within the global specialty healthcare landscape. It offers actionable strategies for improving treatment access, clinical outcomes and cost management to help stakeholders strengthen and streamline the commercialization of specialty pharmaceuticals. #AscellaHealth #SpecialtyPharmacy #Payers #Pharma #LifeSciences #Healthcare #WhitePaper Download the full white paper here: https://lnkd.in/eb-CHn3G

The latest episode of AscellaHealth Podcast Pulse is now live! In this engaging three-part episode, we dive deep into exclusive distribution with industry experts Donovan Quill, EVP of Business Development, Growth & Strategy at AscellaHealth, and Charles Gayer, Chief Commercial Officer at BioCryst Pharmaceuticals, Inc. They explore critical factors influencing the adoption of Exclusive Distribution Models, including:  ·   Product characteristics  ·   Patient and prescriber profiles  ·   Market dynamics  ·   Strategic objectives Don’t miss an insightful discussion on how these patient-centered models can impact the future of healthcare in the rare disease sector. Tune in now: https://lnkd.in/e6BjnCRP #AscellaHealth #Podcast #ExclusiveDistribution #HealthcareStrategy #RareDisease #SpecialtyPharmacy #LifeSciences #Innovation #Spotify

October is American Pharmacists Month! This year’s theme, “Caring for Our Communities,” puts a spotlight on the crucial role pharmacists play in enhancing patient care and supporting their communities. At AscellaHealth, we’re excited to honor our amazing pharmacists who embody this commitment. This week we’re celebrating Brandon Salke PharmD, CSP, EVP, Strategic Solutions for Optime Care, our nationally recognized specialty pharmacy & distribution center. With over a decade of expertise in specialty pharmaceuticals, focused in ultra-orphan, orphan and rare diseases, Brandon has been instrumental in shaping Optime Care’s patient-first approach, leading to improved health outcomes for individuals with chronic complex conditions. Join us in thanking Brandon and all pharmacists for their unwavering dedication to advancing the pharmacy profession and making a meaningful impact on patients’ lives! 👏💊 #AmericanPharmacistMonth #APhM2024 #AscellaHealth #SpecialtyPharmacy

A packed house in Theatre 6 at World Orphan Drug Congress Europe! Gillian Molloy, AscellaHealth Europe shared insights on "Leading the Way: Streamlining Commercialization of Rare Disease Therapies." If you missed it, don’t worry! Stop by Booth 29 to connect with Gillian and our amazing team. Let’s work together on comprehensive solutions for specialty pharmaceutical commercialization and ensure innovative therapies reach those who need them most! #RareDisease #Pharma #Collaboration #WODC #AscellaHealthEurope

Exciting news from AscellaHealth! We’ve just released the latest edition of our Specialty & Rare Pipeline Digest™—the most comprehensive digital resource highlighting new and upcoming specialty and rare disease drugs, cell and gene therapies (CGTs), and biosimilars. This complimentary quarterly publication provides timely updates to support stakeholders and decision-makers in the specialty drug market. Read more in our press release here: https://lnkd.in/gtrwAMRW #AscellaHealth #SpecialtyDrugs #RareDiseases #HealthcareInnovation #CGTs #Biosimilars

With demand increasing in the US, EU and UK markets, it is essential to establish core infrastructures to meet pharmaceutical stakeholder needs while ensuring the ability to maintain control over quality and support. Chairman and President, Bill Oldham, discusses how the recent acquisition of CHAPPER healthcare enhances AscellaHealth’s solution set, extending global capabilities and setting the stage for future growth. https://lnkd.in/e6NydAwh #AscellaHealth #patientcare #specialtypharmacy #pharmaacquisition #pharmaceuticalservices #pharmanews

October is American Pharmacists Month! This year’s theme, “Caring for Our Communities,” spotlights the vital role pharmacists play in enhancing patient care and supporting their communities. We’re thrilled for the opportunity to recognize our amazing pharmacists! This week, we celebrate Andy Szczotka, PharmD, Chief Pharmacy Officer at AscellaHealth. With over 30 years of experience leading clinical specialty and medical drug programs, Andy truly embodies our core value of "putting patients first" and demonstrates a clear commitment to improving patient outcomes. Join us in celebrating Andy and all pharmacists for their unwavering dedication and remarkable contributions to the pharmacy profession. Thank you for all that you do! 👏💊 #AmericanPharmacistMonth #APhM2024 #AscellaHealth #SpecialtyPharmacy

We have some exciting news! AscellaHealth has acquired CHAPPER healthcare—a leader in specialty pharmaceutical wholesale, distribution and services—to bring their global healthcare capabilities under one roof. This strategic move enhances our ability to deliver more direct and efficient product distribution across international markets. Integrating these capabilities supports our commitment to meeting the evolving needs of our clients and improving patient access to cutting-edge therapies. We look forward to the expansive opportunities this acquisition brings. Read more: https://lnkd.in/eZ5bG5tQ #AscellaHealth #specialtypharmaceutical #pharmaindustry #pharmaceuticalaccess #biopharma #pharmaceuticalservices #pharmaacquisition #pharmanews 

Exciting News! Optime Care is expanding our partnership with Rigel Pharmaceuticals! Effective October 14, 2024, we’re thrilled to take on the commercial distribution of TAVALISSE® (fostamatinib, an oral medication designed to manage chronic immune thrombocytopenia (ITP) by protecting platelets from destruction. This expansion enhances our commitment to providing essential therapies to support highly specialized patient populations while optimizing health outcomes. Our comprehensive patient access and HUB services – including patient assistance programs (PAP), co-pay assistance and reimbursement support – are critical to ensuring a high standard of care. Read more in the full press release here: https://lnkd.in/epje85ay #OptimeCare #RigelPharmaceuticals #TAVALISSE #HealthcareInnovation #ChronicITP